| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/09/2009 | US20090092589 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/09/2009 | US20090092582 Compositions and methods for modifying properties of biologically active polypeptides |
| 04/09/2009 | US20090092581 Interferons of rhesus and cynomolgus origin and uses thereof |
| 04/09/2009 | US20090092579 Novel method for down-regulation of amyloid |
| 04/09/2009 | US20090092578 Methods of selecting and producing modified toxins, conjugates containing modified toxins, and uses thereof |
| 04/09/2009 | US20090092557 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/09/2009 | US20090092553 Monocarboxylate transporters expressed in cancer cells |
| 04/09/2009 | DE4021517B4 Formulierungen mit verlangsamter Freisetzung wasserlöslicher Peptide Formulations with delayed release of water-soluble peptides |
| 04/09/2009 | DE19543553B4 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 04/09/2009 | DE10208877B4 Verwendung eines Streptavidin- Bindungspeptides Using a streptavidin-binding peptide |
| 04/09/2009 | DE102007045935A1 Fertilitätstest Fertility Test |
| 04/09/2009 | CA2702025A1 A non-desensitizing mutant of the transient receptor potential trpm5 ion channel |
| 04/09/2009 | CA2701775A1 A novel bacteriocin from a new streptomyces species |
| 04/09/2009 | CA2701694A1 Antigen-binding proteins having specificity for human hepcidin |
| 04/09/2009 | CA2701686A1 Methods of treating cancer using notch pathway inhibitors |
| 04/09/2009 | CA2701612A1 Neuromedin u derivative |
| 04/09/2009 | CA2701521A1 Use of the sequence encoding of the carboxyl-terminal domain of the heavy chain of the tetanus toxin as a drug |
| 04/09/2009 | CA2701215A1 Articular cartilage gene therapy with recombinant vector encoding bmp-7 |
| 04/09/2009 | CA2701198A1 Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease |
| 04/09/2009 | CA2701128A1 Antisense modulation of fibroblast growth factor receptor 4 expression |
| 04/09/2009 | CA2700011A1 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 04/09/2009 | CA2698627A1 System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 04/08/2009 | EP2045329A1 Flagellin mutant vaccine |
| 04/08/2009 | EP2045323A1 Linear expression constructs for production of influenza virus particles |
| 04/08/2009 | EP2045322A1 Double-muscling in mammals |
| 04/08/2009 | EP2045268A1 Mhc class I and II peptide antigens derived from tumour antigen 5t4 |
| 04/08/2009 | EP2045267A2 Humanized antibodies that recognize beta amyloid peptide |
| 04/08/2009 | EP2045266A1 Methods for treating and diagnosing a cancer secreting cath-D or Alzheimer's disease. |
| 04/08/2009 | EP2045265A1 GLP-1 fusion peptides, their production and use |
| 04/08/2009 | EP2045264A2 Novel pH- and anion concentration-responsive GFP mutant, a chimeric protein comprising such a mutant and a method for the combined assaying of the pH and anion concentration |
| 04/08/2009 | EP2045263A1 Identification and molecular characterisation of salivary metalloproteases expressed in the tick salivary glands |
| 04/08/2009 | EP2045262A1 Insecticidal proteins from bacillus thuringiensis |
| 04/08/2009 | EP2045261A1 Chlamydia pneumoniae antigenic polypeptides |
| 04/08/2009 | EP2045260A1 Replication deficient RNA viruses as vaccines |
| 04/08/2009 | EP2045259A1 Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase |
| 04/08/2009 | EP2044953A1 Viral antigens |
| 04/08/2009 | EP2044950A2 Attenuated VIF DNA immunization cassettes for genetic vaccines |
| 04/08/2009 | EP2044947A1 Compositions and methods |
| 04/08/2009 | EP2044116A1 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease |
| 04/08/2009 | EP2044115A2 Pan-cell surface receptor- specific therapeutics |
| 04/08/2009 | EP2044114A2 Method for screening an enhancer or a masker of salty taste |
| 04/08/2009 | EP2044113A2 Glucagon-like peptides and uses thereof |
| 04/08/2009 | EP2044112A2 Thrombopoietic compounds |
| 04/08/2009 | EP2044111A2 Targeting complement factor h for treatment of diseases |
| 04/08/2009 | EP2044110A2 Compositions and methods for inhibiting hiv infections by inhibiting lerepo4 and glipr |
| 04/08/2009 | EP2044109A2 Identification and use of target genes for control of plant parasitic nematodes |
| 04/08/2009 | EP2044108A2 Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same |
| 04/08/2009 | EP2044107A1 Use of plant chromatin remodeling genes for modulating plant architecture and growth |
| 04/08/2009 | EP2044106A2 Bacillus thuringiensis toxin with anti-lepidopteran activity |
| 04/08/2009 | EP2044105A2 Bacillus thuringiensis toxin with anti-lepidopteran activity |
| 04/08/2009 | EP2044104A2 Polypeptides from neisseria meningitidis |
| 04/08/2009 | EP2043693A1 N-terminal polysialylation |
| 04/08/2009 | EP2043692A2 Polysaccharide derivatives of erythropoietin |
| 04/08/2009 | EP2043674A1 Human growth and differentiation factor gdf-5 |
| 04/08/2009 | EP2043671A2 Method and compositions for treating stroke with fever |
| 04/08/2009 | EP2006295A9 Protein having ice nucleating activity |
| 04/08/2009 | EP1774020A4 Phage microarray profiling of the humoral response to disease |
| 04/08/2009 | EP1639007B1 Vegf traps and therapeutic uses thereof |
| 04/08/2009 | EP1539808B1 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 04/08/2009 | EP1505076B1 Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 04/08/2009 | EP1501921B1 Improved viral purification methods |
| 04/08/2009 | EP1482965B1 Method to control tumor progression and invasiveness |
| 04/08/2009 | EP1462518B1 Adipocyte differentiation-associated gene and protein |
| 04/08/2009 | EP1452593B1 Dna synthesis promoters, dna polymerase-associated factors and utilization thereof |
| 04/08/2009 | EP1250353B1 P21 derived peptides capable of inhibiting cdk/cyclin complexes |
| 04/08/2009 | EP1244692B1 Compositions and methods for detecting stress-inducible proteins |
| 04/08/2009 | EP1151143B1 Selection of proteins using rna-protein fusions |
| 04/08/2009 | EP1130961B1 Stabilisation of milk from transgenic animals |
| 04/08/2009 | EP1096953B1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 04/08/2009 | EP0877758B1 PURIFIED SR-p70 PROTEIN |
| 04/08/2009 | EP0861266B3 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 04/08/2009 | CN101405396A Stress resistant plants |
| 04/08/2009 | CN101405394A D-amino acid selection for soybean |
| 04/08/2009 | CN101405391A Water deficiency condition and abscisic acid induced transcription factor gene, promoter and transgenic plant in sunflower |
| 04/08/2009 | CN101405300A Methods and compositions for antagonism of RAGE |
| 04/08/2009 | CN101405299A Glycosylated G-CSF |
| 04/08/2009 | CN101405298A Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use |
| 04/08/2009 | CN101405297A Structure LINGO-1 |
| 04/08/2009 | CN101405296A Novel genes encoding insecticidal proteins |
| 04/08/2009 | CN101405295A Hepatitis C virus variants |
| 04/08/2009 | CN101402970A Gene amplification method |
| 04/08/2009 | CN101402968A Expression method of human anti-zymoplasm III, special-purpose expression vector and engineering bacterium thereof |
| 04/08/2009 | CN101402961A Method for producing glucoprotein vaccine |
| 04/08/2009 | CN101402960A Recombinant rubella virus E1 protein and uses thereof |
| 04/08/2009 | CN101402958A Genetic engineering uses of rice phosphate transfer protein gene OsPht1;6 |
| 04/08/2009 | CN101402957A Rhizophora stylosa reversion carry protein gene, clone and uses thereof |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101402954A Method for expressing recombinant pig lactoferrin N leaf with pichia thermophilic methanol yeast |
| 04/08/2009 | CN101402684A Monoclone mab-bomDpl-9 of antibody anti-cattle maturity Doppel and uses thereof |
| 04/08/2009 | CN101402683A Synthesis of melamine artificial antigen |
| 04/08/2009 | CN101402682A Synthesis of fratol poisonous agent artificial antigen |
| 04/08/2009 | CN101402681A Polypeptide from deer floral disc, preparing method and uses for preventing and treating diabetes |
| 04/08/2009 | CN101402680A Shark liver regeneration factor, preparation method and medical uses thereof |
| 04/08/2009 | CN101402679A Coldproof protein, encoding gene and uses thereof |
| 04/08/2009 | CN101402678A Coldproof protein, encoding gene and uses thereof |
| 04/08/2009 | CN101402677A Quadrant peptide and uses thereof |
| 04/08/2009 | CN101402671A Method simultaneously separating fibrinogen and immunoglobulin from livestock and poultry blood |
| 04/08/2009 | CN100475963C Chicken infectivity bursa of Fabricius virus VP2 cDNA, its expression vector, expressed recombinant protein and application thereof |
| 04/08/2009 | CN100475962C Highly expressed cotton ag2 gene possessing resistance on adversity induced by glyphosate |
| 04/08/2009 | CN100475959C Coagulation factor VII anamorphosis |